Cargando…

Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

Major depressive disorder (MDD) is a chronic illness wherein relapses contribute to significant patient morbidity and mortality. Near-term prediction of relapses in MDD patients has the potential to improve outcomes by helping implement a ‘predict and preempt’ paradigm in clinical care. In this stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vairavan, Srinivasan, Rashidisabet, Homa, Li, Qingqin S., Ness, Seth, Morrison, Randall L., Soares, Claudio N., Uher, Rudolf, Frey, Benicio N., Lam, Raymond W., Kennedy, Sidney H., Trivedi, Madhukar, Drevets, Wayne C., Narayan, Vaibhav A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10616277/ https://www.ncbi.nlm.nih.gov/pubmed/37903878 http://dx.doi.org/10.1038/s41598-023-44592-8

Ejemplares similares

Circulating microRNA associated with future relapse status in major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022)

Predictive modeling of treatment resistant depression using data from STAR*D and an independent clinical study
por: Nie, Zhi, et al.
Publicado: (2018)

Meta-analysis of epigenome-wide association studies of major depressive disorder
por: Li, Qingqin S., et al.
Publicado: (2022)

Replication of machine learning methods to predict treatment outcome with antidepressant medications in patients with major depressive disorder from STAR*D and CAN-BIND-1
por: Nunez, John-Jose, et al.
Publicado: (2021)

“One Degree of Separation”: A Mixed-Methods Evaluation of Canadian Mental Health Care User and Provider Experiences With Remote Care During COVID-19
por: Ceniti, Amanda K., et al.
Publicado: (2022)

Developing an Electroencephalography-Based Model for Predicting Response to Antidepressant Medication
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

Resting-state EEG delta and alpha power predict response to cognitive behavioral therapy in depression: a Canadian biomarker integration network for depression study
por: Schwartzmann, Benjamin, et al.
Publicado: (2023)

A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study
por: Slyepchenko, Anastasiya, et al.
Publicado: (2023)

Integrated genome-wide methylation and expression analyses reveal functional predictors of response to antidepressants
por: Ju, Chelsey, et al.
Publicado: (2019)

The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report
por: Harkness, Kate L., et al.
Publicado: (2023)

Genome-wide association study and polygenic risk score analysis of esketamine treatment response
por: Li, Qingqin S., et al.
Publicado: (2020)

Variations in the FRA10AC1 Fragile Site and 15q21 Are Associated with Cerebrospinal Fluid Aβ(1-42) Level
por: Li, Qingqin S., et al.
Publicado: (2015)

Prediction of depression treatment outcome from multimodal data: a CAN-BIND-1 report
por: Sajjadian, Mehri, et al.
Publicado: (2023)

Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
por: Islam, Farhana, et al.
Publicado: (2022)

Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response
por: Fiori, Laura M., et al.
Publicado: (2021)

Understanding the complex interplay between violence, depression and suicidal ideation in women: Time for a comprehensive sex- and gender-based approach
por: Gonzalez, Andrea, et al.
Publicado: (2020)

Rasch analyses of the Quick Inventory of Depressive Symptomatology Self-Report in neurodegenerative and major depressive disorders
por: Vaccarino, Anthony L., et al.
Publicado: (2023)

Validating the Generalizability of Ophthalmic Artificial Intelligence Models on Real-World Clinical Data
por: Rashidisabet, Homa, et al.
Publicado: (2023)

Disruption in the Blood-Brain Barrier: The Missing Link between Brain and Body Inflammation in Bipolar Disorder?
por: Patel, Jay P., et al.
Publicado: (2015)

Comorbid Premenstrual Dysphoric Disorder and Bipolar Disorder: A Review
por: Slyepchenko, Anastasiya, et al.
Publicado: (2021)

Validation of the intolerance of uncertainty scale as a screening tool for perinatal anxiety
por: Furtado, Melissa, et al.
Publicado: (2021)

Melatonin use during pregnancy and lactation: A scoping review of human studies
por: Vine, Tya, et al.
Publicado: (2021)

Trajectories and changes in individual items of positive and negative syndrome scale among schizophrenia patients prior to impending relapse
por: Wang, Dai, et al.
Publicado: (2018)

Remote Assessment of Disease and Relapse in Major Depressive Disorder (RADAR-MDD): recruitment, retention, and data availability in a longitudinal remote measurement study
por: Matcham, Faith, et al.
Publicado: (2022)

Neuroplasticity in mood disorders
por: Drevets, Wayne C.
Publicado: (2004)

Genome-wide association study meta-analysis of suicide death and suicidal behavior
por: Li, Qingqin S., et al.
Publicado: (2022)

Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study
por: Simpson, William, et al.
Publicado: (2016)

Association Between Side Effects and Blood microRNA Expression Levels and Their Targeted Pathways in Patients With Major Depressive Disorder Treated by a Selective Serotonin Reuptake Inhibitor, Escitalopram: A CAN-BIND-1 Report
por: Yrondi, Antoine, et al.
Publicado: (2019)

Preclinical and Clinical Evidence of Antioxidant Effects of Antidepressant Agents: Implications for the Pathophysiology of Major Depressive Disorder
por: Behr, Guilherme A., et al.
Publicado: (2012)

From anatomy to function: the role of the somatosensory cortex in emotional regulation
por: Kropf, Erika, et al.
Publicado: (2018)

The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study
por: Kuhathasan, Nirushi, et al.
Publicado: (2021)

An investigation of cannabis use for insomnia in depression and anxiety in a naturalistic sample
por: Kuhathasan, Nirushi, et al.
Publicado: (2022)

SNORD90 induces glutamatergic signaling following treatment with monoaminergic antidepressants
por: Lin, Rixing, et al.
Publicado: (2023)

Gene–Environment Interactions in Severe Mental Illness
por: Uher, Rudolf
Publicado: (2014)

Genomics and the classification of mental illness: focus on broader categories
por: Uher, Rudolf
Publicado: (2013)

Use of Machine Learning for Predicting Escitalopram Treatment Outcome From Electroencephalography Recordings in Adult Patients With Depression
por: Zhdanov, Andrey, et al.
Publicado: (2020)

PHYSICAL HARBINGERS OF RELAPSE IN SCHIZOPHRENIA
por: Srinivasan, T.N., et al.
Publicado: (1994)

Comparative Efficacy of the Generalized Anxiety Disorder 7-Item Scale and the Edinburgh Postnatal Depression Scale as Screening Tools for Generalized Anxiety Disorder in Pregnancy and the Postpartum Period
por: Simpson, William, et al.
Publicado: (2014)

Translational Research in Bipolar Disorders
por: Machado-Vieira, Rodrigo, et al.
Publicado: (2015)

Minocycline and aspirin in the treatment of bipolar depression: a protocol for a proof-of-concept, randomised, double-blind, placebo-controlled, 2×2 clinical trial
por: Savitz, Jonathan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_dri5d07sbjhr5b9d5tp7098eh4